Naoki Terakawa
No ORCID on file
· 77 papers in corpus
· active 1986-2021
Study types
- article 62
- review 6
- other 3
- book-chapter 2
- case-report 1
Condition tags
- endometriosis 56
- endometrioma 9
- infertility 6
- chronic_pelvic_pain 4
- dysmenorrhea 3
- dyspareunia 3
- adenomyosis 1
Top journals
Frequent coauthors
- Takashi Harada 61
- Terakawa N 49
- Fuminori Taniguchi 43
- Tomio Iwabe 42
- Harada T 39
- Iwabe T 27
- Taniguchi F 25
- Masao Izawa 18
- Tagashira Y 13
- Izawa M 11
rct
2021
BACKGROUND: Relugolix is a once-daily, oral, nonpeptide, gonadotropin-releasing hormone receptor antagonist. The aim of this study was to evaluate safety of relugolix over 24 weeks in women with endometriosis-associated pain. METHODS: This…
article
2020
ObjectiveTo evaluate the efficacy and safety of three dose levels of relugolix, a gonadotropin-releasing hormone receptor antagonist, compared with placebo and leuprorelin in women with endometriosis-associated pain.DesignPhase 2, multicent…
article
2017
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
article
2016
article
2015
article
2014
OBJECTIVE: To investigate the clinical features of patients in Japan with malignant transformation of ovarian endometrioma. PATIENTS: Thirty-three patients diagnosed with ovarian cancer presumably arising from endometrioma were recruited re…
article
2014
article
2014
review
2013
Endometriosis is an estrogen-dependent inflammatory disease. In endometriotic tissues, a high-estrogen environment associated with up-regulation of the aromatase gene has been well documented. There is accumulating evidence supporting a con…
article
2013
ObjectiveThe objective of this study was to determine the genes that may be associated with malignant transformation of ovarian endometrioma.MethodsEndometriotic epithelial cells were isolated from tissues derived from chocolate cyst lining…
article
2012
AIMS: We investigated the potential of gonadotropin-releasing hormone (GnRH) agonists and GnRH antagonists to inhibit cell proliferation in endometriotic and endometrial stromal cells. METHODS: Twenty patients with ovarian endometriomas and…
article
2012
article
2012
review
2012
The nuclear factor kappaB (NF-kappaB) is a ubiquitously expressed transcription factor playing vital roles in innate immunity and other processes involving cellular survival, proliferation, and differentiation. This review highlights the im…
book-chapter
2011
book-chapter
2011
article
2011
article
2010
article
2010
review
2010
Apoptosis is a distinctive form of programmed cell death resulting in the efficient elimination of cells without eliciting an inflammatory response. Endometriosis is characterized by the presence of endometrial cells with capacity to avoid …
article
2010
ObjectiveTo search for the demethylated cytosine-phosphate-guanine (CpG) islands within the aromatase gene in stromal cells derived from endometriotic chocolate cysts.DesignProspective study.SettingDepartment of Obstetrics and Gynecology an…
article
2009
Lipopolysaccharide-enhanced cyclooxygenase 2 (COX-2) expression and prostaglandin E2 (PGE2) production were compared in endometriotic stromal cells (ESCs) and eutopic endometrial stromal cells. Lipopolysaccharide promotes the proliferation …
other
2009
AIM: To investigate the safety and efficacy of 52 weeks of dienogest treatment in patients with endometriosis. METHODS: One hundred and thirty-five patients with endometriosis received 2 mg of dienogest orally each day for 52 weeks. Advers…
article
2009
PROBLEM: We previously reported that lipopolysaccharide (LPS)-promoted endometriotic stromal cell (ESC) proliferation by inducing TNFalpha production. The aim of this study was to investigate the efficacy of TNFalpha gene silencing on LPS-t…
article
2009